TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Bio-Works Sweden AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
16,538
|
29,484
|
27,647 |
| Financial expenses |
6
|
1
|
13 |
| Earnings before taxes |
-22,871
|
-34,922
|
-27,927 |
| EBITDA |
-22,676
|
-35,090
|
-28,173 |
| Total assets |
14,241
|
16,510
|
27,835 |
| Current assets |
13,061
|
14,839
|
26,209 |
| Current liabilities |
4,711
|
10,465
|
14,269 |
| Equity capital |
9,529
|
6,045
|
13,566 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
31
|
33
|
35 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
66.9%
|
36.6%
|
48.7% |
| Turnover per employee |
533
|
893
|
790 |
| Profit as a percentage of turnover |
-138.3%
|
-118.4%
|
-101.0% |
| Return on assets (ROA) |
-160.6%
|
-211.5%
|
-100.3% |
| Current ratio |
277.2%
|
141.8%
|
183.7% |
| Return on equity (ROE) |
-240.0%
|
-577.7%
|
-205.9% |
| Change turnover |
-11,970
|
1,695
|
12,970 |
| Change turnover % |
-42%
|
6%
|
88% |
| Chg. No. of employees |
-2
|
-2
|
8 |
| Chg. No. of employees % |
-6%
|
-6%
|
30% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.